Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
topic_facet:"Lung Neoplasms"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&lookfor=%22610%22&type=Subject&page=6
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&lookfor=%22610%22&type=Subject&page=6
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Lung+Neoplasms%22&lookfor=%22610%22&type=Subject&page=6
PubPharm (1.977)
51
Osimertinib In EGFR Mutant Lung Cancer : A Phase II Study of Osimertinib With On-study and Post-progression Biopsy in the First Line Treatment of EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
52
Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab : Phase 2 Trial of Neoadjuvant KRAS G12C Directed Therapy With Adagrasib (MRTX849) With or Without Nivolumab in Resectable Non-Small Cell Lung Cancer (Neo-KAN)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
53
Daratumumab in STK11 Mutated NSCLC : A Single-Arm Phase 2 Study of Daratumumab Subcutaneous (SC) in Previously Treated STK11/LKB1 Mutated Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
54
A Study of BGB-A445 in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung Cancer : A Phase 2, Open-label, Randomized, Multi-arm Study of BGB-A445 in Combination With Investigational Agents in Non-Small Cell Lung Cancer Patients Previously Treated With Anti-PD-(L)1 Antibody
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
55
Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic Squamous or Non-Squamous NSCLC : A Randomized Trial of Durvalumab and Tremelimumab ± Platinum-Based Chemotherapy in Patients With Metastatic (Stage IV) Squamous or Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
56
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy : A Phase II, Randomised Study of Nivolumab as Consolidation Therapy in Patients With Locally Advanced, Unresectable Non-Small Cell Lung Cancer (Stage III) Who Have Not Progressed Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
57
Safety and Efficacy of Intravenous Cemiplimab Plus BNT116 Versus Cemiplimab Alone in Advanced Non-Small Cell Lung Cancer in Adult Participants With PD-L1 ≥ 50% : A Phase 2 Study of Cemiplimab (Anti-PD-1 Antibody) in Combination With BNT116 (FixVac Lung) Versus Cemiplimab Monotherapy in First-Line Treatment of Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) With Tumors Expressing PD-L1 ≥50%
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
58
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib : A Multicenter Single-arm Phase II Interventional Study to Evaluate the Activity and Safety of the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on Lorlatinib.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
59
Durvalumab Followed by Chemoradiation and Consolidation Durvalumab for Stage III Non-small Cell Lung Cancer : Induction Durvalumab Followed by Chemoradiation and Consolidation Durvalumab (MEDI4736) for Stage III Non-small Cell Lung Cancer
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
60
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors : Phase 2 Study of Avapritinib in Patients With CKIT or PDGFRA Mutation-Positive Malignant Solid Tumors
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
[1]
« Vorheriger
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[198]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Lung Neoplasms
Medienart
1.977
Aufsätze
1.977
E-Artikel
1.977
E-Ressourcen
Zeitschriftentitel
1.977
ClinicalTrials.gov
Thema
1.977
610
Lung Neoplasms
Phase: Phase 2
1.977
Study Type: Interventional
1.355
Carcinoma, Non-Small-Cell Lung
690
Recruitment Status: Completed
396
Recruitment Status: Recruiting
293
Small Cell Lung Carcinoma
265
Recruitment Status: Terminated
203
Recruitment Status: Active, not recruiting
185
Recruitment Status: Unknown status
172
Medical Condition: Lung Cancer
144
Medical Condition: Non-small Cell Lung Cancer
136
Recruitment Status: Not yet recruiting
119
Carcinoma
117
Medical Condition: Non Small Cell Lung Cancer
102
Medical Condition: Non-Small Cell Lung Cancer
93
Recruitment Status: Withdrawn
72
Neoplasm Metastasis
67
Medical Condition: Small Cell Lung Cancer
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.093
2020-
826
2010-2019
58
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.977
Englisch
Haven't found what you're looking for?
Wird geladen...